A detailed history of Bellevue Group Ag transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bellevue Group Ag holds 337,633 shares of BDX stock, worth $76.9 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
337,633
Previous 347,333 2.79%
Holding current value
$76.9 Million
Previous $81.2 Million 0.28%
% of portfolio
1.37%
Previous 1.36%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$221.47 - $242.41 $2.15 Million - $2.35 Million
-9,700 Reduced 2.79%
337,633 $81.4 Million
Q2 2024

Aug 14, 2024

SELL
$225.07 - $246.17 $15.4 Million - $16.8 Million
-68,367 Reduced 16.45%
347,333 $81.2 Million
Q1 2024

May 15, 2024

BUY
$233.45 - $247.73 $6.45 Million - $6.85 Million
27,632 Added 7.12%
415,700 $103 Million
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $19.5 Million - $22.4 Million
83,838 Added 27.56%
388,068 $94.6 Million
Q3 2023

Nov 14, 2023

SELL
$254.9 - $283.59 $8.54 Million - $9.5 Million
-33,493 Reduced 9.92%
304,230 $78.7 Million
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $2.46 Million - $2.74 Million
-10,320 Reduced 2.97%
337,723 $89.2 Million
Q1 2023

May 15, 2023

BUY
$229.71 - $259.35 $3.79 Million - $4.27 Million
16,483 Added 4.97%
348,043 $86.2 Million
Q4 2022

Feb 14, 2023

SELL
$218.29 - $256.91 $715,554 - $842,150
-3,278 Reduced 0.98%
331,560 $84.3 Million
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $415,588 - $2.15 Million
-8,144 Reduced 2.37%
334,838 $74.6 Million
Q2 2022

Aug 11, 2022

SELL
$234.74 - $275.42 $12.5 Million - $14.7 Million
-53,423 Reduced 13.48%
342,982 $84.6 Million
Q1 2022

May 13, 2022

SELL
$243.64 - $270.48 $14.4 Million - $16 Million
-59,007 Reduced 12.96%
396,405 $105 Million
Q4 2021

Feb 10, 2022

SELL
$230.08 - $250.94 $36,812 - $40,150
-160 Reduced 0.04%
455,412 $115 Million
Q3 2021

Nov 12, 2021

SELL
$232.72 - $256.47 $1.26 Million - $1.38 Million
-5,393 Reduced 1.17%
455,572 $112 Million
Q1 2021

May 12, 2021

BUY
$232.09 - $256.88 $30.9 Million - $34.2 Million
133,209 Added 40.64%
460,965 $112 Million
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $14.8 Million - $16.5 Million
66,910 Added 25.65%
327,756 $82 Million
Q3 2020

Nov 16, 2020

BUY
$215.77 - $276.76 $3.22 Million - $4.13 Million
14,906 Added 6.06%
260,846 $60.7 Million
Q2 2020

Aug 13, 2020

SELL
$219.9 - $263.41 $247,167 - $296,072
-1,124 Reduced 0.45%
245,940 $58.8 Million
Q1 2020

May 14, 2020

SELL
$195.69 - $279.01 $968,274 - $1.38 Million
-4,948 Reduced 1.96%
247,064 $56.8 Million
Q4 2019

Feb 14, 2020

BUY
$236.45 - $266.82 $12.1 Million - $13.7 Million
51,185 Added 25.49%
252,012 $68.5 Million
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $11.8 Million - $13.1 Million
51,135 Added 34.16%
200,827 $50.8 Million
Q2 2019

Aug 14, 2019

BUY
$217.4 - $246.08 $4.5 Million - $5.1 Million
20,720 Added 16.07%
149,692 $37.7 Million
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $1.46 Million - $1.76 Million
7,100 Added 5.83%
128,972 $32.2 Million
Q4 2018

Feb 12, 2019

BUY
$204.73 - $257.93 $3.37 Million - $4.25 Million
16,459 Added 15.61%
121,872 $27.5 Million
Q3 2018

Nov 13, 2018

BUY
$233.07 - $256.0 $5.64 Million - $6.19 Million
24,198 Added 29.79%
105,413 $27.5 Million
Q2 2018

Aug 07, 2018

BUY
$208.1 - $233.85 $6.5 Million - $7.3 Million
31,215 Added 62.43%
81,215 $19.5 Million
Q1 2018

May 09, 2018

SELL
$205.46 - $240.27 $1.03 Million - $1.2 Million
-5,000 Reduced 9.09%
50,000 $10.8 Million
Q3 2017

Nov 13, 2017

BUY
$186.89 - $198.9 $560,670 - $596,700
3,000 Added 5.77%
55,000 $10.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
52,000
52,000 $10.1 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.